	US 11,788,070 B2
	Uridine diphosphate-dependent glycosyltransferase enzyme
Jason Eric Donald, Watertown, MA (US); Ajikumar Parayil Kumaran, Lexington, MA (US); Aaron Love, Cambridge, MA (US); Christopher Toomey, Cambridge, MA (US); and Christine Nicole S. Santos, Newton, MA (US)
Assigned to Manus Bio Inc., Cambridge, MA (US)
Filed by Manus Bio Inc., Cambridge, MA (US)
Filed on Oct. 6, 2021, as Appl. No. 17/495,139.
Application 17/495,139 is a continuation of application No. 16/912,374, filed on Jun. 25, 2020, granted, now 11,168,309.
Claims priority of provisional application 62/866,148, filed on Jun. 25, 2019.
Prior Publication US 2022/0090031 A1, Mar. 24, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 9/10 (2006.01); C12P 19/56 (2006.01); C12N 15/52 (2006.01)

CPC C12N 9/1051 (2013.01) [C12N 15/52 (2013.01); C12P 19/56 (2013.01)]

18 Claims

1. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO: 9.